Home > Compound List > Compound details
191217-81-9 molecular structure
click picture or here to close

(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride

ChemBase ID: 72839
Molecular Formular: C10H21Cl2N3OS
Molecular Mass: 302.26424
Monoisotopic Mass: 301.07823867
SMILES and InChIs

SMILES:
[C@@H]1(CCc2c(C1)sc(n2)N)NCCC.Cl.Cl.O
Canonical SMILES:
CCCN[C@H]1CCc2c(C1)sc(n2)N.O.Cl.Cl
InChI:
InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1
InChIKey:
APVQOOKHDZVJEX-QTPLPEIMSA-N

Cite this record

CBID:72839 http://www.chembase.cn/molecule-72839.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride
IUPAC Traditional name
pramipexole hydrate dihydrochloride
Synonyms
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrate dihydrochloride
Mirapex
Mirapexin
Sifrol
Pramipexole dihydrochloride monohy
CAS Number
191217-81-9
MDL Number
MFCD02183927
PubChem SID
162037760
PubChem CID
166589

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 166589 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 17.661047  H Acceptors
H Donor LogD (pH = 5.5) -1.5217185 
LogD (pH = 7.4) -0.98125774  Log P 1.7642827 
Molar Refractivity 59.7672 cm3 Polarizability 22.761166 Å3
Polar Surface Area 50.94 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Hydrophobicity(logP)
1.168 expand Show data source
Storage Condition
-20°C expand Show data source
Purity
95% expand Show data source
Salt Data
Coordination Co expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S2011 external link
Research Area: Neurological Disease
Biological Activity:
Pramipexole is a partial/full D2S, D2L, D3, D4, receptor agonist with a Ki of 3.9, 2.2, 0.5, 5.1 nM. It also possesses low/insignificant affinity (500-10,000 nM) for the 5-HT1A, 5-HT1B, 5-HT1D, and α2-adrenergic receptors. It has negligible affinity (>10,000 nM) for the D1, D5, 5-HT2, α1-adrenergic, β-adrenergic, H1, and mACh receptors. It is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson’s disease (PD) and restless legs syndrome (RLS). [1][2][3]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Pramipexole
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle